Preparing for Disease Y: A Better Serological Toolbox
This article was originally published on Clinical Lab Manager. It’s been over a year since the World Health Organization (WHO) declared COVID-19 a pandemic. SARS-CoV-2 has since infected 200 million people, resulting in nearly 4 million deaths and substantial economic...
Making Sense of the SARS-CoV-2 Spike Mutations
Through much of 2020, SARS-CoV-2 accumulated mutations at a steady, yet unspectacular rate. However, as global cases approached 100 million by the end of the year, multiple variants began to emerge. Exhibiting more considerable genomic changes, some variants have...
Lyme Disease: A Rapidly Emerging Bacterial Infection in Need of New Diagnostics
This article was first published on Clinical Lab Products. Lyme disease is now the most common and fastest growing vector-borne illness in the Western world. A two-tiered antibody testing approach is currently used for clinical diagnosis, but suffers from several...
The Yearly Race for an Influenza Vaccine and the Role of Reagents
In this blog, we explain how seasonal and pandemic influenza vaccines are developed, manufactured and validated, and introduce our contract services for the rapid development of custom influenza reagents. The Influenza Viruses: A Quick Recap The influenza viruses are...